» Articles » PMID: 10791883

Introduction to Porcine Red Blood Cells: Implications for Xenotransfusion

Overview
Journal Semin Hematol
Specialty Hematology
Date 2000 May 3
PMID 10791883
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in the field of xenotransplantation raise the intriguing possibility of using porcine red blood cells (pRBCs) as an alternative source for blood transfusion. The domestic pig is considered the most likely donor species for xenotransplantation. However, identification of xenoantigens on porcine erythrocytes and elucidation of their possible roles in antibody-mediated RBC destruction are necessary for developing clinical strategies to circumvent immunological incompatibility between humans and pigs. Although the alphaGal epitope (Galalpha1,3Galbeta1,4GIcNAc-R) is the major xenoantigen on porcine erythrocytes and is responsible for the binding of the majority of human natural antibodies, other non-alphaGal xenoantigens have been identified. The importance of these non-alphaGal xenoantigens in binding human natural antibodies and subsequently triggering immunological responses cannot be underestimated. Our data suggest that non-alphaGal xenoantigen(s) identified on the porcine erythrocyte membrane are not only recognized by xenoreactive human natural antibodies but are also involved in complement-mediated hemolysis.

Citing Articles

Biological response of nonhuman primates to controlled levels of acute blood loss.

Roh J, Park E, Lee H, Hwang J, Kim H, Park J Front Immunol. 2024; 14:1286632.

PMID: 38268927 PMC: 10806063. DOI: 10.3389/fimmu.2023.1286632.


Effect of Lactylate and on Growth Performance, Peripheral Blood Cell Profile, and Gut Microbiota of Nursery Pigs.

Wang X, Tsai T, Wei X, Zuo B, Davis E, Rehberger T Microorganisms. 2021; 9(4).

PMID: 33920300 PMC: 8070655. DOI: 10.3390/microorganisms9040803.


Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?.

Smood B, Hara H, Schoel L, Cooper D Blood Rev. 2019; 35:7-17.

PMID: 30711308 PMC: 6467751. DOI: 10.1016/j.blre.2019.01.003.